• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Hofseth BioCare

Less than 1K followers

HBC

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

Hofseth BioCare is a Norwegian company active in biotechnology. The company develops various protein and calcium powders, as well as salmon oil. By using patented technology, the company can extract substances for production at an early stage. The products are delivered in the form of dietary supplements and sold through health stores. The company was founded in 2009 and has its headquarters in Ålesund.

Read more
Market cap
-
Turnover
-
Revenue
254.43M
EBIT %
-44.16 %
P/E
-
Dividend yield-%
-
Financial calendar
30.7
2026

Extraordinary general meeting '26

21.8
2026

Interim report Q2'26

6.11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Regulatory press release09.07.2026, 19.19

HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Hofseth BioCare
Regulatory press release07.07.2026, 17.00

HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION

Hofseth BioCare
Regulatory press release07.07.2026, 16.59

HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION

Hofseth BioCare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release03.07.2026, 13.43

HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED

Hofseth BioCare
Regulatory press release30.06.2026, 12.50

HOFSETH BIOCARE ASA: ANNUAL GENERAL MEETING COMPLETED

Hofseth BioCare
Regulatory press release30.06.2026, 12.13

HOFSETH BIOCARE ASA: FIRST QUARTER 2026 FINANCIAL REPORT AND NEW COMMERCIAL UPDATE FOR CURRENT TRADING

Hofseth BioCare
Regulatory press release29.06.2026, 14.28

HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE

Hofseth BioCare
Regulatory press release29.06.2026, 12.01

HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS

Hofseth BioCare
Regulatory press release29.06.2026, 12.01

HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS

Hofseth BioCare
Regulatory press release29.06.2026, 11.58

HOFSETH BIOCARE ASA – VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS

Hofseth BioCare
Regulatory press release28.06.2026, 23.51

HOFSETH BIOCARE ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED

Hofseth BioCare
Regulatory press release26.06.2026, 16.55

HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT

Hofseth BioCare
Regulatory press release09.06.2026, 21.01

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026

Hofseth BioCare
Regulatory press release28.05.2026, 19.01

HBC: Financial calendar

Hofseth BioCare
Regulatory press release22.05.2026, 01.22

Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M

Hofseth BioCare
Regulatory press release06.05.2026, 20.45

HBC: Financial calendar

Hofseth BioCare
Regulatory press release14.04.2026, 11.03

Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas

Hofseth BioCare
Regulatory press release14.04.2026, 11.03

Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas

Hofseth BioCare
Regulatory press release27.03.2026, 17.08

Hofseth BioCare ASA: HBC ANNUAL REPORT 2025

Hofseth BioCare
Regulatory press release13.02.2026, 08.15

Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT

Hofseth BioCare